scholarly journals COVID-19 Vaccine Concerns about Safety, Effectiveness and Policies in the United States, Canada, Sweden, and Italy among Unvaccinated Individuals

Author(s):  
Rachael Piltch-Loeb ◽  
Nigel Harriman ◽  
Julia Healey ◽  
Marco Bonetti ◽  
Veronica Toffolutti ◽  
...  

AbstractDespite the effectiveness of the COVID-19 vaccine, global vaccination distribution efforts have thus far had varying levels of success. Vaccine hesitancy remains a threat to vaccine uptake. This study has four objectives: 1) describe and compare vaccine hesitancy proportions by country; 2) categorize vaccine-related concerns; 3) rank vaccine-related concerns; and 4) compare vaccine-related concerns by country and hesitancy status in four countries- the United States, Canada, Sweden, and Italy. Using the Pollfish survey platform, we sampled 1000 respondents in Canada, Sweden, and Italy and 750 respondents in the United States between May 21-28, 2021. Results showed vaccine related concerns varied across three topical areas- vaccine safety and government control, vaccine effectiveness and population control, and freedom. For each thematic area, the top concern was statistically significantly different in each country and among the hesitant and non-hesitant subsamples within each county. Understanding the specific concerns among individuals when it comes to the COVID-19 vaccine can help to inform public communications and identify which, if any, salient narratives, are global.

Vaccines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1138
Author(s):  
Rachael Piltch-Loeb ◽  
Nigel Walsh Harriman ◽  
Julia Healey ◽  
Marco Bonetti ◽  
Veronica Toffolutti ◽  
...  

Despite the effectiveness of the COVID-19 vaccine, global vaccination distribution efforts have thus far had varying levels of success. Vaccine hesitancy remains a threat to vaccine uptake. This study has four objectives: (1) describe and compare vaccine hesitancy proportions by country; (2) categorize vaccine-related concerns; (3) rank vaccine-related concerns; and (4) compare vaccine-related concerns by country and hesitancy status in four countries—the United States, Canada, Sweden, and Italy. Using the Pollfish survey platform, we sampled 1000 respondents in Canada, Sweden, and Italy and 750 respondents in the United States between 21–28 May 2021. Results showed vaccine-related concerns varied across three topical areas—vaccine safety and government control, vaccine effectiveness and population control, and freedom. For each thematic area, the top concern was statistically significantly different in each country and among the hesitant and non-hesitant subsamples within each county. Concerns related to freedom were the most universal. Understanding the specific concerns among individuals when it comes to the COVID-19 vaccine can help to inform public communications and identify which, if any, salient narratives are global.


Vaccines ◽  
2021 ◽  
Vol 9 (12) ◽  
pp. 1418
Author(s):  
Rachel S. Purvis ◽  
Emily Hallgren ◽  
Ramey A. Moore ◽  
Don E. Willis ◽  
Spencer Hall ◽  
...  

The World Health Organization has identified vaccine hesitancy as a top health concern. Emerging research shows that those who are hesitant may still get vaccinated; however, little is known about those who say they are hesitant but still get vaccinated. Most people have high trust in several sources of COVID-19 information, and trust in certain information sources such as the Centers for Disease Control and Prevention and health care providers was associated with being vaccinated. This study explored trusted information sources among hesitant adopters in the United States with a survey respondents completed while waiting after receiving a COVID-19 vaccine dose. The study included (n = 867) respondents. The majority of respondents were female (60.21%); were between the ages of 18 and 44 years old (71.97%); and were diverse, with most identifying as White (44.54%) or Hispanic/Latinx (32.55%). Hesitant adopters reported multiple trusted sources of COVID-19 vaccine information, which can be grouped into four emergent subthemes: (1) Health care/Medical science, (2) Personal relationships, (3) News and social media, and (4) Individual/Myself. Some respondents expressed a distrust of all sources of COVID-19 vaccine information, despite receiving the vaccine, describing a lack of trust in traditional sources of information such as the mainstream media or government. This study contributes to the literature by documenting trusted sources of COVID-19 vaccine information among hesitant adopters in the United States. Findings provide important insights about respondents’ trusted sources of COVID-19 vaccine information that can inform future public health messaging campaigns intended to increase vaccine uptake among hesitant adopters.


Vaccines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 901
Author(s):  
Sarah E. Kreps ◽  
Jillian L. Goldfarb ◽  
John S. Brownstein ◽  
Douglas L. Kriner

While mass vaccination has blunted the pandemic in the United States, pockets of vaccine hesitancy remain. Through a nationally representative survey of 1027 adult Americans conducted in February 2021, this study examined individual misconceptions about COVID-19 vaccine safety; the demographic factors associated with these misconceptions; and the relationship between misconceptions and willingness to vaccinate. Misconceptions about vaccine safety were widespread. A sizeable minority (40%) believed that vaccine side effects are commonly severe or somewhat severe; 85% significantly underestimated the size and scale of the clinical trials; and a sizeable share believed either that the vaccines contain live coronavirus (10%) or were unsure (38%), a proxy for fears that vaccination itself may cause infection. These misconceptions were particularly acute among Republicans, Blacks, individuals with lower levels of educational attainment, and unvaccinated individuals. Perceived side effect severity and underestimating the size of the clinical trials were both significantly associated with vaccine hesitancy.


2021 ◽  
pp. ASN.2021010104
Author(s):  
Pablo Garcia ◽  
Maria E. Montez-Rath ◽  
Heather Moore ◽  
Johnie Flotte ◽  
Chris Fults ◽  
...  

BackgroundPatients on dialysis are at increased risk for COVID-19–related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination.MethodsWith the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons.ResultsA total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18–44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18–44 years versus those 45–64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders’ main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively).ConclusionsA substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects.


Vaccines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 858
Author(s):  
Lynn M. Baniak ◽  
Faith S. Luyster ◽  
Claire A. Raible ◽  
Ellesha E. McCray ◽  
Patrick J. Strollo

Even with the availability of COVID-19 vaccines, factors associated with vaccine hesitancy and uptake among nurses are unknown. This study evaluated COVID-19 vaccine hesitancy and uptake of nursing staff during one of the first COVID-19 vaccine rollouts in the United States. A cross-sectional survey was conducted during February 2021 among nursing staff working in a large medical center in central United States. There were 276 respondents; 81.9% of participants were willing to receive the vaccine during the initial rollout, 11.2% were hesitant, and only 5.1% were unwilling. The hesitant group was likely to report having inadequate information to make an informed decision about whether to receive the vaccine (45.2%) and about vaccine expectations (32.3%). The majority (83.3%) received at least one dose of the vaccine. Having greater than 10 years’ work experience (OR 3.0, 95% CI 1.16–7.9) and confidence in vaccine safety (OR 7.78, 95% CI 4.49–13.5) were significantly associated with vaccine uptake. While our study indicates higher vaccine uptake among nursing staff during an active vaccine rollout, there remains sustained hesitancy and unwillingness to uptake. For those hesitant to receive the COVID-19 vaccine, public health efforts to provide more data on side effects and efficacy may help increase vaccine uptake.


2017 ◽  
Author(s):  
Sandra Goldlust ◽  
Elizabeth C. Lee ◽  
Murali Haran ◽  
Pejman Rohani ◽  
Shweta Bansal

AbstractDespite advances in sanitation and immunization, vaccine-preventable diseases remain a significant cause of morbidity and mortality worldwide. In high-income countries such as the United States, coverage rates for vaccination against childhood infections remains high. However, the phenomenon of vaccine hesitancy makes maintenance of herd immunity difficult, impeding global disease eradication efforts. Reaching the ‘last mile’ will require early detection of vaccine hesitancy (driven by philosophical or religious choices), identifying pockets of susceptibility due to underimmunization (driven by vaccine unavailability, costs ineligibility), determining the factors associated with the behavior and developing targeted strategies to ameliorate the concerns. Towards this goal, we harness high-resolution medical claims data to geographically localize vaccine refusal and underimmunization (collectively, ‘underutilization’) in the United States and identify the socio-economic determinants of the behaviors. Our study represents the first large-scale effort for vaccination behavior surveillance and has the potential to aid in the development of targeted public health strategies for optimizing vaccine uptake.


2022 ◽  
Author(s):  
Asaf Mazar ◽  
Geoffrey Tomaino ◽  
Ziv Carmon ◽  
Wendy Wood

COVID-19 remains a leading cause of death in the United States, despite wide availability of vaccines. Distance may pose an overlooked barrier to vaccine uptake. We analyzed the association between distance to vaccine sites and vaccination rates. Zip codes farther away from vaccine sites had consistently lower vaccine uptake. This effect persisted after controlling for potent covariates (e.g., partisanship, vaccine hesitancy), as well as in multiverse analyses testing across more than 1,000 specifications. Suggesting that the effect was not explained by reverse causality (i.e. proximity driven by demand), the distance effect maintained in analyses limited only to retail locations (e.g., CVS), whose location was set pre-pandemic. Findings suggest that reducing distance to vaccine sites as a powerful lever for encouraging COVID-19 vaccination.


Vaccines ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 31
Author(s):  
Celia B. Fisher ◽  
Aaliyah Gray ◽  
Isabelle Sheck

On 29 October 2021, the U.S. FDA authorized the Pfizer-BioNTech COVID-19 (SARS-CoV-2) vaccine for emergency use in children ages 5–11 years. Racial/ethnic minorities have born the greatest burden of pediatric COVID-19 infection and hospitalization. Research indicates high prevalence of parental vaccine hesitancy among the general population, underscoring the urgency of understanding how race/ethnicity may influence parents’ decision to vaccinate their children. Two weeks prior to FDA approval, 400 Hispanic and non-Hispanic Asian, Black, and White parents of children 5–10 years participated in an online survey assessing determinants of COVID-19 pediatric vaccine hesitancy. Compared to 31% Black, 45% Hispanic, and 25% White parents, 62% of Asian parents planned to vaccinate their child. Bivariate and multivariate ordinal logistic regression demonstrated race/ethnicity, parental vaccine status, education, financial security, perceived childhood COVID-19 susceptibility and severity, vaccine safety and efficacy concerns, community support, and FDA and physician recommendations accounted for 70.3% of variance for vaccine hesitancy. Findings underscore the importance of multipronged population targeted approaches to increase pediatric COVID-19 vaccine uptake including integrating health science literacy with safety and efficacy messaging, communication efforts tailored to parents who express unwillingness to vaccinate, and interventions developed in partnership with and delivered through existing trusted community coalitions.


Author(s):  
Sandra Goldlust ◽  
Elizabeth Lee ◽  
Shweta Bansal

ObjectiveThe purpose of this study was to investigate the use of large-scalemedical claims data for local surveillance of under-immunizationfor childhood infections in the United States, to develop a statisticalframework for integrating disparate data sources on surveillance ofvaccination behavior, and to identify the determinants of vaccinehesitancy behavior.IntroductionIn the United States, surveillance of vaccine uptake for childhoodinfections is limited in scope and spatial resolution. The NationalImmunization Survey (NIS) - the gold standard tool for monitoringvaccine uptake among children aged 19-35 months - is typicallyconstrained to producing coarse state-level estimates.1In recent years,vaccine hesitancy (i.e., a desire to delay or refuse vaccination, despiteavailability of vaccination services)2has resurged in the United States,challenging the maintenance of herd immunity. In December 2014,foreign importation of the measles virus to Disney theme parks inOrange County, California resulted in an outbreak of 111 measlescases, 45% of which were among unvaccinated individuals.3Digitalhealth data offer new opportunities to study the social determinantsof vaccine hesitancy in the United States and identify finer spatialresolution clusters of under-immunization using data with greaterclinical accuracy and rationale for hesitancy.4MethodsOur U.S. medical claims data comprised monthly reports ofdiagnosis codes for under-immunization and vaccine refusal(Figure 1). These claims were aggregated to five-digit zip-codes bypatient age-group from 2012 to 2015. Spatial generalized linear mixedmodels were used to generate county-level maps for surveillanceof under-immunization and to identify the determinants of vaccinehesitancy, such as income, education, household size, religious grouprepresentation, and healthcare access. We developed a Bayesianmodeling framework that separates the observation of vaccinehesitancy in our data from true underlying rates of vaccine hesitancyin the community. Our model structure also enabled us to borrowinformation from neighboring counties, which improves predictionof vaccine hesitancy in areas with missing or minimal data. Estimatesof the posterior distributions of model parameters were generated viaMarkov chain Monte Carlo (MCMC) methods.ResultsOur modeling framework enabled the production of county-levelmaps of under-immunization and vaccine refusal in the UnitedStates between 2012-2015, the identification of geographic clustersof under-immunization, and the quantification of the associationbetween various epidemiological factors and vaccination status.In addition, we found that our model structure enabled us to accountfor spatial variation in reporting vaccine hesitancy, which improvedour estimation.ConclusionsOur work demonstrate the utility of using large-scale medicalclaims data to improve surveillance systems for vaccine uptake andto assess the social and ecological determinants of vaccine hesitancy.We describe a flexible, hierarchical modeling framework forintegrating disparate data sources, particularly for data collectedthrough different measurement processes or at different spatial scales.Our findings will enhance our understanding of the causes of under-immunization, inform the design of vaccination policy, and aid inthe development of targeted public health strategies for optimizingvaccine uptake.Figure 1. Instances of vaccine refusal (per 100,000 population) for UnitedStates counties in 2014 as observed in medical claims data.


Author(s):  
Mark W Tenforde ◽  
H Keipp Talbot ◽  
Christopher H Trabue ◽  
Manjusha Gaglani ◽  
Tresa M McNeal ◽  
...  

Abstract Background Influenza causes significant morbidity and mortality and stresses hospital resources during periods of increased circulation. We evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalizations in the United States. Methods We included adults hospitalized with acute respiratory illness at 14 hospitals and tested for influenza viruses by reserve transcription polymerase chain reaction. Vaccine effectiveness (VE) was estimated by comparing the odds of current-season influenza vaccination in test-positive influenza cases versus test-negative controls, adjusting for confounders. VE was stratified by age and major circulating influenza types along with A(H1N1)pdm09 genetic subgroups. Results 3116 participants were included, including 18% (553) influenza-positive cases. Median age was 63 years. Sixty-seven percent (2079) received vaccination. Overall adjusted VE against influenza viruses was 41% (95% confidence interval [CI]: 27-52). VE against A(H1N1)pdm09 viruses was 40% (95% CI: 24-53) and 33% against B viruses (95% CI: 0-56). Of the two major A(H1N1)pdm09 subgroups (representing 90% of sequenced H1N1 viruses), VE against one group (5A+187A,189E) was 59% (95% CI: 34-75) whereas no significant VE was observed against the other group (5A+156K) [-1%, 95% CI: -61-37]. Conclusions In a primarily older population, influenza vaccination was associated with a 41% reduction in risk of hospitalized influenza illness.


Sign in / Sign up

Export Citation Format

Share Document